MYC and Burkitt lymphoma: Particularly, CS2164 showed superior antilymphoma activity against MYC-arranged Burkitt lymphoma than other types of lymphoma, suggesting this agent might have a cytotoxic effect on other MYC-altered malignancies, containing HGBL-DHL (32).